Skip to main content
Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.180
-0.135 (-4.07%)
May 14, 2025, 10:48 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Interventional Pulmonology
83.79M
Log In
Log In
Log In
Log In
Upgrade
Interventional Pulmonology Growth
22.01%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
United States
56.47M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
22.97%
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle-East and Africa
22.33M
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle-East and Africa Growth
61.31%
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific
4.44M
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific Growth
46.84%
Log In
Log In
Log In
Log In
Upgrade
Other International
556.00K
Log In
Log In
Log In
Log In
Upgrade
Other International Growth
39.35%
Log In
Log In
Log In
Log In
Upgrade
Germany
-
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-
Log In
Log In
Log In
Log In
Upgrade
France
-
Log In
Log In
Log In
Log In
Upgrade